Enhanced Recovery after Caesarean Section

The Final FRCA syllabus calls for knowledge of "the principles of enhanced recovery programmes", whilst the Primary FRCA syllabus expects an understanding of "organisational interventions which improve patient outcomes (eg care bundles, enhanced recovery programmes)".

There's not yet been a CRQ on this topic, although enhanced recovery for other surgeries has appeared before (September 2025).

Resources



Definition

  • Enhanced recovery after Caesarean section (ERAC) is an evidence-based, structured approach to perioperative care designed to optimise maternal and neonatal outcomes
  • It spans the antenatal period through to the postpartum period and discharge
  • Endorsed by the ERAS Society, NICE and the Society for Obstetric Anesthesia and Perinatology (SOAP)

Aims

  • Reduce the physiological stress of surgery
  • Promote faster recovery and return to normal function
  • Enhance the maternal experience and maternal–neonatal bonding
  • Improve the efficiency of healthcare delivery and reduce costs

How ERAC differs from general ERAS

  • Two patients: care must address both maternal and neonatal needs; bonding, breastfeeding and neonatal health all influence length of stay
  • Patients are typically young and fit, and perioperative mortality is extremely low
  • There is a long, predictable antenatal period offering a unique window for optimisation
  • Much of standard UK practice (spinal anaesthesia, minimal fasting, oral analgesia, early mobilisation) was already compatible with enhanced recovery before formal pathways were introduced

Core principles

  • Multidisciplinary team working: midwives, obstetricians, anaesthetists, neonatologists and management
  • Patient-centred care and shared decision making
  • Standardisation of care, often supported by checklists
  • Measurement of outcomes and compliance to drive ongoing improvement

Benefits

  • Meta-analyses of ERAC implementation show:
    • Reduced pain scores and opioid consumption
    • Shorter time to mobilisation and urinary catheter removal
    • Reduced length of stay and lower healthcare costs
    • No increase in readmission or complication rates
  • Improved maternal satisfaction; many women are positive about next day discharge when it is offered
  • In the UK, approximately 40% of women having an elective Caesarean section now go home the day after surgery

Evidence for individual components is often limited or extrapolated from other specialties; much of the guidance is based on the assumption that best practice standard care should lead to a more timely recovery.


Components of enhanced recovery after caesarean section


Antenatal education

  • Empowers women to take an active role in their care, sets expectations and supports shared decision making
  • Improves engagement with the pathway, obstetric outcomes and maternal experience
  • Discussion of the risks and benefits of each mode of delivery should begin around 16 weeks, with birth preference provisionally finalised by 28 weeks
  • Information can be verbal, written or digital (accessible on mobile phones); educational videos appear most effective at reducing anxiety
  • Women having a repeat Caesarean section are more likely to achieve next day discharge, suggesting that well-informed women recover more quickly

Multidisciplinary staff education

  • Continuous education and checklists help maintain adherence and consistent practice
  • Local champions from each discipline lead implementation and quality improvement
  • Hospital management involvement secures organisational support and resources

Preparation for breastfeeding

  • The WHO recommends exclusive breastfeeding for the first 6 months of life
  • Benefits include fewer infections and reduced SIDS in infants, and long-term protection against diabetes and breast and ovarian cancer in mothers
  • Support can be offered through prenatal classes, information leaflets and support groups

Optimisation of medical conditions

The extended antenatal period allows multidisciplinary optimisation of comorbidities associated with adverse obstetric and neonatal outcomes.


Comorbidity Optimisation
Anaemia Identify and correct iron deficiency; oral iron first line, IV iron if severe
Diabetes Tight glycaemic control (fasting < 5.3 mmol/L); insulin preferred
Chronic hypertension Target BP < 140/90 mmHg (labetalol, nifedipine, methyldopa)
Obesity Lifestyle interventions; specific surgical and anaesthetic planning
Congenital heart disease Modified WHO risk stratification; MDT care from preconception
Epilepsy Avoid abrupt cessation of antiseizure drugs; continue folic acid
Asthma Regular symptom review; self-management education
Smoking Cessation as early as possible; behavioural counselling

Abdominal skin preparation

  • Bathing or showering with 2% chlorhexidine before elective Caesarean section is recommended
  • Evidence in obstetrics is limited (largely extrapolated from other specialties) but it is a low-risk intervention

Limiting the duration of fasting

  • Pregnancy increases aspiration risk through delayed gastric emptying, raised intra-abdominal pressure and reduced lower oesophageal sphincter tone
  • However, prolonged fasting causes hypovolaemia, hypoglycaemia, ketosis, thirst and anxiety
  • Conventional guidance: light meal up to 6 h and clear fluids up to 2 h before surgery
  • 'Sip til send': women are encouraged to sip water until called to theatre
    • Reduces nausea, light-headedness, thirst and anxiety
    • Gastric ultrasound studies show no difference in gastric antral cross-sectional area compared with standard fasting
    • Well suited to obstetric lists where delays and cancellations are common
  • Scheduling first on the list makes next day discharge more likely

Carbohydrate loading

  • A nonparticulate drink containing 45 g carbohydrate taken 2 h before surgery (e.g. pulp-free apple juice or sports drinks)
  • Benefits:
    • Reduced insulin resistance
    • Shorter time to colostrum expression and breastfeeding, with longer and more frequent feeds
    • Reduced neonatal hypoglycaemia
  • Effects on maternal ketosis and nausea and vomiting are inconsistent
  • Use with caution in diabetic mothers

Premedication

  • Antacid prophylaxis (e.g. H2 antagonist) is indicated given the risk of aspiration should general anaesthesia be required
  • Sedative premedication is avoided due to the risk of neonatal depression
  • Bowel preparation is not required

Support person in theatre

  • A partner, relative, doula or midwife; reduces maternal anxiety and increases satisfaction

Anaesthetic technique

  • Neuraxial anaesthesia is preferred over general anaesthesia:
    • Less blood loss and a reduced stress response
    • Less PONV and earlier return to oral intake
    • Allows long-acting neuraxial opioids for postoperative analgesia
  • Spinal is faster in onset than epidural with less intraoperative pain; outcomes are otherwise similar

Prevention and management of spinal hypotension

  • Hypotension follows sympathetic blockade and systemic vasodilation, causing maternal nausea, vomiting and dizziness
  • Uteroplacental blood flow is not autoregulated; prolonged hypotension risks fetal bradycardia and neonatal acidosis
  • Aim to maintain systolic BP ≥ 90% of baseline, avoiding a fall below 80%
  • Strategies:
    • Left lateral uterine displacement
    • Crystalloid coload at the time of neuraxial block
    • Prophylactic vasopressor infusion, titrated to heart rate and BP

Optimisation of IV fluids

  • Aim for euvolaemia; pregnant women are more susceptible to fluid shifts
  • Limit IV fluids to <3L for routine Caesarean section unless there is haemorrhage
  • Even greater caution in pre-eclampsia and cardiac disease

Maintenance of normothermia

  • Hypothermia (core temperature <36°C) is common and mainly caused by neuraxial anaesthesia:
    • Vasodilation redistributes heat from core to periphery
    • Central thermoregulation is impaired, lowering the thresholds for shivering and vasoconstriction
    • Efferent nerves responsible for shivering and vasoconstriction are blocked
  • Measure temperature before induction and every 30 minutes thereafter
  • Methods: warm theatre (≥ 23°C), passive warming (a single blanket reduces skin heat loss by up to 30%), warmed IV fluids and forced air warming
  • Combining warmed fluids with forced air warming has not been shown to be superior to either alone

  • Consequences of hypothermia
    • Maternal shivering and discomfort
    • Increased blood loss and transfusion
    • Surgical site infection
    • Delayed PACU and hospital discharge
    • Neonatal hypothermia, lower umbilical artery pH and a barrier to skin-to-skin contact

Infection prophylaxis

  • Sepsis remains a leading cause of direct maternal death
  • Single-dose IV antibiotics given within 60 minutes before skin incision (rather than after cord clamping) reduce endometritis and wound infection, without harm to the neonate
  • Abdominal skin: chlorhexidine-alcohol is superior to povidone iodine for reducing surgical site infection
  • Vaginal preparation (chlorhexidine or povidone iodine) reduces endometritis and postoperative pyrexia; evidence is strongest in labouring women

Delayed umbilical cord clamping

  • Delay for at least 30–60 seconds to allow placental transfusion to the neonate
  • Term neonates: higher haemoglobin, better iron stores and improved neurodevelopment
  • Preterm neonates: improved transitional circulation and fewer transfusions, cases of necrotising enterocolitis and intraventricular haemorrhage
  • No increased risk of postpartum haemorrhage; timing of oxytocin does not affect placental transfusion
  • Increased risk of neonatal jaundice; local protocols should identify those needing phototherapy

  • Contraindications:
    • Compromised placental circulation
    • Neonate requiring immediate resuscitation

Optimising uterotonics

  • Uterine atony is the most common cause of postpartum haemorrhage
  • The aim is adequate uterine tone using the lowest effective dose of a first-line agent, escalating promptly to second-line drugs when required
  • Oxytocin should be given slowly (no faster than 1 IU every 10 seconds) to limit haemodynamic effects
  • Ergometrine is probably the most effective second-line agent, but choice should follow local guidance and patient comorbidities

PONV prophylaxis

  • Combination prophylaxis with a 5-HT3 antagonist and dexamethasone is superior to monotherapy
  • Dexamethasone is preferred as it also lowers pain scores and reduces opioid requirement
    • Raises blood glucose by up to ~1 mmol/L in the first 24 h; safe in diabetics with reasonable control
    • In diabetic mothers give after delivery to avoid neonatal hypoglycaemia
    • When compared to a standard 6.6mg dose, higher dose dexamethasone (25mg at delivery and 25mg 24hrs post-delivery) shows improvements in pain scores, opioid use, quality of recovery and satisfaction (BJA, 2026)
  • Surgical factors: avoid uterine exteriorisation and intra-abdominal saline irrigation, which increase nausea without reducing blood loss

Multimodal analgesia

  • Caesarean section causes moderate to severe pain; multimodal analgesia is commenced intraoperatively
  • Long-acting neuraxial opioids are the gold standard, providing up to 26 h of analgesia

Route Diamorphine Morphine
Intrathecal 300 mcg 50–150 mcg
Epidural 2–3 mg 2–3 mg

  • Consider CSE where high analgesic requirements are expected (e.g. chronic pain), allowing repeat epidural dosing
  • PROSPECT recommends preoperative or intraoperative paracetamol and an intraoperative NSAID, continued regularly afterwards
  • Dexamethasone 8 mg IV contributes to analgesia as well as antiemesis
  • Where long-acting neuraxial opioids have not been given (e.g. general anaesthesia), consider truncal blocks: TAP, quadratus lumborum, ilioinguinal-iliohypogastric or erector spinae plane; none is consistently superior
  • Adding blocks to neuraxial opioids gives little additional benefit, except perhaps in selected women at risk of severe pain

Early skin-to-skin contact

  • Maternal benefits: improved breastfeeding success, satisfaction, uterine tone and less blood loss and pain
  • Neonatal benefits: more stable heart rate, earlier feeding behaviours and less crying

Continuation of multimodal analgesia

  • Around one in five women experience severe acute pain after Caesarean section, which affects mental health, bonding, breastfeeding and the risk of chronic pain
  • Regular paracetamol and NSAID (unless contraindicated), with oral opioids as required for breakthrough pain
  • Scheduled analgesia is superior to analgesia on request
  • The oral route is preferred; IV paracetamol and NSAIDs offer no advantage and cost more
  • Opioids are rarely needed after discharge; avoid routinely sending women home with strong opioids

Standardised rescue protocol for side-effects

  • Side-effects of neuraxial anaesthesia and opioids affect up to 80% of women, so rescue medication should be prescribed pre-emptively

Side-effect Rescue treatment
Nausea and vomiting Ondansetron first line; alternatives include cyclizine, dopamine antagonists or a scopolamine patch
Pruritus Nalbuphine, low-dose naloxone or ondansetron
Shivering Pethidine, tramadol or dexmedetomidine
Constipation Laxatives, mobilisation and hydration
Respiratory depression (~1.5 per 10,000) Urgent medical review and naloxone; enhanced monitoring if high risk (e.g. morbid obesity)

Early oral intake

  • Fluids in PACU (ice chips or water) and a light diet within 1–2 h after regional anaesthesia
  • Associated with earlier return of bowel function, mobilisation and catheter removal, without more nausea or ileus
  • Chewing gum speeds return of bowel function if oral intake must be delayed
  • Diabetes: insulin requirements fall sharply after delivery and breastfeeding increases hypoglycaemia risk; reduce or stop treatment and monitor glucose closely

Early discontinuation of IV fluids

  • Reduces infection, thrombophlebitis and fluid overload while aiding mobility
  • Stop once the patient is haemodynamically stable, tolerating oral fluids without nausea, passing adequate urine and the oxytocin infusion is complete

Promotion of rest

  • Poor sleep after Caesarean section is linked with postnatal depression, worse pain and breastfeeding difficulty
  • Cluster observations, drug rounds and investigations; tailor monitoring frequency to clinical status
  • Treat pain and nausea effectively

Early mobilisation

  • Improves bowel function and reduces deconditioning and VTE risk
  • Sitting out or transferring to a chair within 6–8 h, once motor function has returned, under supervision
  • Motor block persisting 6 h after neuraxial anaesthesia warrants urgent review to exclude complications such as epidural haematoma

Early removal of the urinary catheter

  • Reduces urinary tract infection and improves comfort, mobility and length of stay
  • ERAS Society and SOAP recommend removal 6–12 h after delivery once mobile
  • No increase in recatheterisation has been shown, though the optimal timing after long-acting neuraxial opioids is uncertain

VTE prophylaxis

  • VTE risk is higher after Caesarean section than vaginal delivery
  • Mechanical prophylaxis (e.g. pneumatic compression devices) until fully ambulatory
  • Risk assess before surgery and again at the WHO checklist sign-out
  • Pharmacological prophylaxis for those at high risk; LMWH is generally preferred, with unfractionated heparin reserved for those at high bleeding risk
  • Heparins increase the risk of wound haematoma and dehiscence, so routine use in all women is not recommended

Anaemia

  • Postpartum anaemia is common and causes fatigue, impaired wound healing, infection and depression
  • Routine testing is unnecessary; check Hb on day 1 or 2 if at high risk (significant blood loss, pre-existing anaemia or symptoms)
  • Treat with oral or IV iron; IV iron gives a greater rise in Hb at 6 weeks
  • Consider transfusion on an individual basis if Hb < 70 g/L or symptomatic; liberal transfusion confers no benefit

Breastfeeding support

  • Breastfeeding difficulty is common and linked to poorer maternal mental health
  • Early skin-to-skin contact, counselling, educational material and access to lactation specialists increase breastfeeding initiation and duration
  • Intention to breastfeed may lengthen stay while feeding is established

Facilitation of early discharge

  • Planning starts before surgery: patient goals, neonatal care, contraception and lactation education, involving the support person
  • The appropriate day of discharge is decided postoperatively; next day discharge is unsuitable for some (e.g. significant comorbidity)
  • Early discharge does not increase readmission, pain or wound infection
  • More than 80% of Caesarean wound infections present after discharge, so women need written and verbal information on normal recovery, warning signs and how to seek help
  • Community midwifery support and outpatient follow-up within 6 weeks

Core outcome set

  • Maternal outcomes:
    • Length of stay
    • Readmission and unplanned reattendance within 30 days
    • Satisfaction with analgesia
    • Inpatient opioid consumption and the proportion requiring opioids
    • Postoperative nausea and vomiting
    • Obstetric Quality of Recovery 10 (ObsQoR-10) score at 24–48 h
  • Process measures:
    • Compliance with the pathway
    • Preoperative fasting duration for liquids
    • Time to first drink, first food and first mobilisation
    • Time to urinary catheter removal
  • Neonatal outcome: breastfeeding at discharge

Patient-reported outcome measures (PROMs)

  • Standardised questionnaires capturing symptoms, function and quality of life; cheap and non-invasive
  • Postpartum recovery covers many domains (physical, psychological, sleep, fatigue, infant feeding), but most PROMs assess only one
  • ObsQoR-10: best validated measure of global inpatient recovery after any mode of delivery
  • STORK (Stanford Obstetric Recovery ChecKlist): developed to assess all domains of outpatient postpartum recovery